These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 36516446)

  • 1. Design, Synthesis, and Evaluation of DFO-Em: A Modular Chelator with Octadentate Chelation for Optimal Zirconium-89 Radiochemistry.
    Salih AK; Raheem SJ; Garcia MD; Ahiahonu WK; Price EW
    Inorg Chem; 2022 Dec; 61(51):20964-20976. PubMed ID: 36516446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DFO-Km: A Modular Chelator as a New Chemical Tool for the Construction of Zirconium-89-Based Radiopharmaceuticals.
    Salih AK; Dominguez Garcia M; Raheem SJ; Ahiahonu WK; Price EW
    Inorg Chem; 2023 Dec; 62(50):20806-20819. PubMed ID: 37751491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89.
    Sarbisheh EK; Salih AK; Raheem SJ; Lewis JS; Price EW
    Inorg Chem; 2020 Aug; 59(16):11715-11727. PubMed ID: 32799484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
    Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.
    Brandt M; Cowell J; Aulsebrook ML; Gasser G; Mindt TL
    J Biol Inorg Chem; 2020 Aug; 25(5):789-796. PubMed ID: 32661784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic versus Noncyclic Chelating Scaffold for
    Summer D; Garousi J; Oroujeni M; Mitran B; Andersson KG; Vorobyeva A; Löfblom J; Orlova A; Tolmachev V; Decristoforo C
    Mol Pharm; 2018 Jan; 15(1):175-185. PubMed ID: 29160082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiochemical, Computational, and Spectroscopic Evaluation of High-Denticity Desferrioxamine Derivatives DFO2 and DFO2p toward an Ideal Zirconium-89 Chelate Platform.
    Khozeimeh Sarbisheh E; Summers KL; Salih AK; Cotelesage JJH; Zimmerling A; Pickering IJ; George GN; Price EW
    Inorg Chem; 2023 Feb; 62(6):2637-2651. PubMed ID: 36716427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of bifunctional DFO2K: a modular chelator with ideal properties for zirconium-89 chelation.
    Salih AK; Khozeimeh Sarbisheh E; Raheem SJ; Dominguez-Garcia M; Mehlhorn HH; Price EW
    Dalton Trans; 2024 Jul; ():. PubMed ID: 39041240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing
    Cho H; Al-Saden N; Lam H; Möbus J; Reilly RM; Winnik MA
    Nucl Med Biol; 2020; 84-85():11-19. PubMed ID: 31931305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for
    Raavé R; Sandker G; Adumeau P; Jacobsen CB; Mangin F; Meyer M; Moreau M; Bernhard C; Da Costa L; Dubois A; Goncalves V; Gustafsson M; Rijpkema M; Boerman O; Chambron JC; Heskamp S; Denat F
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1966-1977. PubMed ID: 31161258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro evaluation of new bifunctional
    Klasen B; Lemcke D; Mindt TL; Gasser G; Rösch F
    Nucl Med Biol; 2021; 102-103():12-23. PubMed ID: 34242949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light-Induced Radiosynthesis of
    Klingler S; Fay R; Holland JP
    J Nucl Med; 2020 Jul; 61(7):1072-1078. PubMed ID: 31924725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89.
    Zhai C; He S; Ye Y; Rangger C; Kaeopookum P; Summer D; Haas H; Kremser L; Lindner H; Foster J; Sosabowski J; Decristoforo C
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30845658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Zirconium-89 Chelator Development.
    Bhatt NB; Pandya DN; Wadas TJ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29534538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine-Directed Site-Selective Bioconjugation for the Creation of Radioimmunoconjugates.
    Sarrett SM; Rodriguez C; Rymarczyk G; Hosny MM; Keinänen O; Delaney S; Thau S; Krantz BA; Zeglis BM
    Bioconjug Chem; 2022 Sep; 33(9):1750-1760. PubMed ID: 35946495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total-Body PET and Highly Stable Chelators Together Enable Meaningful
    Berg E; Gill H; Marik J; Ogasawara A; Williams S; van Dongen G; Vugts D; Cherry SR; Tarantal AF
    J Nucl Med; 2020 Mar; 61(3):453-460. PubMed ID: 31562219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).
    Deri MA; Ponnala S; Zeglis BM; Pohl G; Dannenberg JJ; Lewis JS; Francesconi LC
    J Med Chem; 2014 Jun; 57(11):4849-60. PubMed ID: 24814511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B.
    Ma MT; Meszaros LK; Paterson BM; Berry DJ; Cooper MS; Ma Y; Hider RC; Blower PJ
    Dalton Trans; 2015 Mar; 44(11):4884-900. PubMed ID: 25351250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional Desferrichrome Analogues as Versatile
    Adams CJ; Wilson JJ; Boros E
    Mol Pharm; 2017 Aug; 14(8):2831-2842. PubMed ID: 28665620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.